Visions of Hope: Continuing to Beat AML

Elie Traer, MD
Karin Rodland, PhD
Lee Greenberger, PhD

The fight to effectively treat and cure the complex disease of acute myeloid leukemia (AML) continues.

In this episode, we speak to Dr. Elie Traer, Dr. Karin Rodland and Dr. Lee Greenberger about an exciting new study for AML. The doctors share about a longtime collaboration between Oregon Health & Science University (OHSU) and Pacific Northwest National Laboratory (PNNL) using patient samples from LLS’s Beat AML Master Clinical Trial to further understand the proteins on the cancer cells, resulting in the development of more targeted treatments for AML patients.  

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: Abbvie Inc. and Genentech, Inc. & Biogen.

1 Comment

  1. I am an AML survivor. One day(Nov 5,2022) I was a perfectly healthy 69 yr old woman…next day I wasn’t. I was taken to Mass General Hospital where I was diagnosed, treated and received a stem cell transplant all within 3 months. The trial I was in was for the drug gilteritinib which targeted my FLT3 mutation. I believe I had THE very best care possible and have felt great for the last 14 months. Listening to this podcast reenforces my belief in just how lucky I was and how the extensive research for this disease did in fact save my life.

Leave a Comment

Your email address will not be published. Required fields are marked *